Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-17-217947
Filing Date
2017-06-29
Accepted
2017-06-29 13:40:47
Documents
19

Document Format Files

Seq Description Document Type Size
1 424B4 d14176d424b4.htm 424B4 1898642
2 GRAPHIC g14176g16t06.jpg GRAPHIC 138300
3 GRAPHIC g14176g24i51.jpg GRAPHIC 100576
4 GRAPHIC g14176g29x09.jpg GRAPHIC 62826
5 GRAPHIC g14176g33x25.jpg GRAPHIC 41790
6 GRAPHIC g14176g34m66.jpg GRAPHIC 74279
7 GRAPHIC g14176g48g11.jpg GRAPHIC 82308
8 GRAPHIC g14176g48g54.jpg GRAPHIC 95647
9 GRAPHIC g14176g49o72.jpg GRAPHIC 52285
10 GRAPHIC g14176g49x24.jpg GRAPHIC 87980
11 GRAPHIC g14176g56q31.jpg GRAPHIC 115886
12 GRAPHIC g14176g58k25.jpg GRAPHIC 78468
13 GRAPHIC g14176g63u83.jpg GRAPHIC 81464
14 GRAPHIC g14176g75u22.jpg GRAPHIC 51829
15 GRAPHIC g14176g83g13.jpg GRAPHIC 29484
16 GRAPHIC g14176g83l86.jpg GRAPHIC 146472
17 GRAPHIC g14176g84k83.jpg GRAPHIC 189948
18 GRAPHIC g14176g85x25.jpg GRAPHIC 95011
19 GRAPHIC g14176g98v10.jpg GRAPHIC 103344
  Complete submission text file 0001193125-17-217947.txt   4140897
Mailing Address 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address 281 ALBANY STREET CAMBRIDGE MA 02139 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-218474 | Film No.: 17937720
SIC: 2834 Pharmaceutical Preparations